idelalisib 150 MG Oral Tablet [Zydelig]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

idelalisib 150 MG Oral Tablet [Zydelig]

150 MG · Oral Tablet · oral

A form of idelalisib →

idelalisib 150 MG Oral Tablet [Zydelig] — Phosphatidylinositol-3-kinase (Pi3K) inhibitors. Strength, form, class, interactions & more.

idelalisib 150 MG Oral Tablet [Zydelig]

Active ingredient

Classification

Phosphatidylinositol-3-kinase (Pi3K) inhibitorsKinase Inhibitor

Drug interactions

Idelalisib has significant interactions with strong CYP3A modulators that can affect its concentrations and efficacy.

  • majorstrong CYP3A inhibitors — may increase idelalisib concentrations
  • majorstrong CYP3A inducers — may decrease idelalisib concentrations
  • majorsensitive CYP3A substrates — may increase concentrations of CYP3A substrates

Real-world adverse events (FAERS)

Disease Progression1,225Death802Diarrhoea771Off Label Use572Pneumonia437Pyrexia375Drug Ineffective317Fatigue301

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.